HETEROCYCLIC BENZAMIDE DERIVATIVES AS CANNABINOID CB1 RECEPTOR ANTAGONISTS
The present invention relates to a novel heterocyclic benzamide compound or a pharmaceutically acceptable salt thereof which acts as an inverse-agonist or an antagonist of cannabinoid CB1 receptor. The compound, according to the present invention, can be valuably used for preventing or treating obes...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; kor |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | CHOI, EUN BOK OH, JUNG TAEK YANG, HEUI CHERL KIM, KWANG ROK LEE, HYEON KYU JANG, TAEG SU |
| description | The present invention relates to a novel heterocyclic benzamide compound or a pharmaceutically acceptable salt thereof which acts as an inverse-agonist or an antagonist of cannabinoid CB1 receptor. The compound, according to the present invention, can be valuably used for preventing or treating obesity or obesity-related metabolic diseases. In addition, the present invention provides a method for manufacturing a heterocyclic benzamide compound, a pharmaceutical composition comprising the same, and a method for preventing or treating obesity and obesity-related metabolic diseases. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20140100724A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20140100724A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20140100724A3</originalsourceid><addsrcrecordid>eNqNyr0KwjAQAOAsDqK-w0FnIakF58vltOdPIkko6FKKxEm0UN8fFx_A6Vu-uTq0nDkGutJJCCz7G57FMTiO0mGWjhNgAkLv0YoP4oCsgcjElxwioM-4D15STks1ewzPqax-LlS140ztuozvvkzjcC-v8umPsdam0Ubrbd3g5r_1BRi_Ljk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HETEROCYCLIC BENZAMIDE DERIVATIVES AS CANNABINOID CB1 RECEPTOR ANTAGONISTS</title><source>esp@cenet</source><creator>CHOI, EUN BOK ; OH, JUNG TAEK ; YANG, HEUI CHERL ; KIM, KWANG ROK ; LEE, HYEON KYU ; JANG, TAEG SU</creator><creatorcontrib>CHOI, EUN BOK ; OH, JUNG TAEK ; YANG, HEUI CHERL ; KIM, KWANG ROK ; LEE, HYEON KYU ; JANG, TAEG SU</creatorcontrib><description>The present invention relates to a novel heterocyclic benzamide compound or a pharmaceutically acceptable salt thereof which acts as an inverse-agonist or an antagonist of cannabinoid CB1 receptor. The compound, according to the present invention, can be valuably used for preventing or treating obesity or obesity-related metabolic diseases. In addition, the present invention provides a method for manufacturing a heterocyclic benzamide compound, a pharmaceutical composition comprising the same, and a method for preventing or treating obesity and obesity-related metabolic diseases.</description><language>eng ; kor</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140818&DB=EPODOC&CC=KR&NR=20140100724A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140818&DB=EPODOC&CC=KR&NR=20140100724A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CHOI, EUN BOK</creatorcontrib><creatorcontrib>OH, JUNG TAEK</creatorcontrib><creatorcontrib>YANG, HEUI CHERL</creatorcontrib><creatorcontrib>KIM, KWANG ROK</creatorcontrib><creatorcontrib>LEE, HYEON KYU</creatorcontrib><creatorcontrib>JANG, TAEG SU</creatorcontrib><title>HETEROCYCLIC BENZAMIDE DERIVATIVES AS CANNABINOID CB1 RECEPTOR ANTAGONISTS</title><description>The present invention relates to a novel heterocyclic benzamide compound or a pharmaceutically acceptable salt thereof which acts as an inverse-agonist or an antagonist of cannabinoid CB1 receptor. The compound, according to the present invention, can be valuably used for preventing or treating obesity or obesity-related metabolic diseases. In addition, the present invention provides a method for manufacturing a heterocyclic benzamide compound, a pharmaceutical composition comprising the same, and a method for preventing or treating obesity and obesity-related metabolic diseases.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyr0KwjAQAOAsDqK-w0FnIakF58vltOdPIkko6FKKxEm0UN8fFx_A6Vu-uTq0nDkGutJJCCz7G57FMTiO0mGWjhNgAkLv0YoP4oCsgcjElxwioM-4D15STks1ewzPqax-LlS140ztuozvvkzjcC-v8umPsdam0Ubrbd3g5r_1BRi_Ljk</recordid><startdate>20140818</startdate><enddate>20140818</enddate><creator>CHOI, EUN BOK</creator><creator>OH, JUNG TAEK</creator><creator>YANG, HEUI CHERL</creator><creator>KIM, KWANG ROK</creator><creator>LEE, HYEON KYU</creator><creator>JANG, TAEG SU</creator><scope>EVB</scope></search><sort><creationdate>20140818</creationdate><title>HETEROCYCLIC BENZAMIDE DERIVATIVES AS CANNABINOID CB1 RECEPTOR ANTAGONISTS</title><author>CHOI, EUN BOK ; OH, JUNG TAEK ; YANG, HEUI CHERL ; KIM, KWANG ROK ; LEE, HYEON KYU ; JANG, TAEG SU</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20140100724A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; kor</language><creationdate>2014</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CHOI, EUN BOK</creatorcontrib><creatorcontrib>OH, JUNG TAEK</creatorcontrib><creatorcontrib>YANG, HEUI CHERL</creatorcontrib><creatorcontrib>KIM, KWANG ROK</creatorcontrib><creatorcontrib>LEE, HYEON KYU</creatorcontrib><creatorcontrib>JANG, TAEG SU</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CHOI, EUN BOK</au><au>OH, JUNG TAEK</au><au>YANG, HEUI CHERL</au><au>KIM, KWANG ROK</au><au>LEE, HYEON KYU</au><au>JANG, TAEG SU</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HETEROCYCLIC BENZAMIDE DERIVATIVES AS CANNABINOID CB1 RECEPTOR ANTAGONISTS</title><date>2014-08-18</date><risdate>2014</risdate><abstract>The present invention relates to a novel heterocyclic benzamide compound or a pharmaceutically acceptable salt thereof which acts as an inverse-agonist or an antagonist of cannabinoid CB1 receptor. The compound, according to the present invention, can be valuably used for preventing or treating obesity or obesity-related metabolic diseases. In addition, the present invention provides a method for manufacturing a heterocyclic benzamide compound, a pharmaceutical composition comprising the same, and a method for preventing or treating obesity and obesity-related metabolic diseases.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; kor |
| recordid | cdi_epo_espacenet_KR20140100724A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | HETEROCYCLIC BENZAMIDE DERIVATIVES AS CANNABINOID CB1 RECEPTOR ANTAGONISTS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T04%3A27%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CHOI,%20EUN%20BOK&rft.date=2014-08-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20140100724A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |